(Q34084115)

30 July 2017

1 reference

title

Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes (English)

1 reference

30 July 2017

Buchfelder M

1

1 reference

30 July 2017

Fahlbusch R

2

1 reference

30 July 2017

Merz T

3

1 reference

30 July 2017

Symowski H

4

1 reference

30 July 2017

Adams EF

5

1 reference

30 July 2017

publication date

1 May 1999

1 reference

30 July 2017

1 reference

30 July 2017

volume

1

1 reference

30 July 2017

issue

3-4

1 reference

30 July 2017

page(s)

181-185

1 reference

A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours

30 July 2017

cites work

1 reference

12 December 2020

Epidemiology and pathogenesis of pituitary adenomas.

1 reference

12 December 2020

GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

1 reference

12 December 2020

Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: in vitro cell culture studies

1 reference

12 December 2020

Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors

1 reference

12 December 2020

Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer

1 reference

12 December 2020

Further evidence for a somatic mutation theory in the pathogenesis of human pituitary tumors

1 reference

12 December 2020

Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas

1 reference

12 December 2020

Molecular biology of growth-hormone-secreting human pituitary tumours: biochemical consequences and potential clinical significance

1 reference

12 December 2020

Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas

1 reference

12 December 2020

Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase

1 reference

12 December 2020

Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group

1 reference

12 December 2020

Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein

1 reference

12 December 2020

Characteristics of acromegalic patients with a good response to octreotide, a somatostatin analogue

1 reference

12 December 2020

Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations

1 reference

12 December 2020

Surgical management of acromegaly

1 reference

12 December 2020

Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1009905131334

1 reference

Dimensions Publication ID

30 July 2017

1011269152

0 references

1 reference